CHIP-BCIS3
A trial to investigate whether a heart pump improves the safety and effectiveness of high-risk coronary artery stenting procedures.
CHIP-BCIS3 is a 6-year research study, based in the UK which began in July 2020. The study aims to recruit 300 participants who are undergoing high-risk coronary artery stenting procedures. The aim of the research is to understand whether the use of a heart pump device impacts the safety and effectiveness of the high-risk stenting procedure. This will be evaluated using a randomised controlled trial study design.
Recent updates
Events
Newsletter
Contact us
CHIP-BCIS3 Clinical Trials Unit
Department of Medical Statistics
London School of Hygiene and Tropical Medicine
Keppel Street
London WC1E 7HT
About the study
Over 100,000 coronary stent procedures, where small balloons are used to stretch open a narrowed blood vessel, are performed every year in the UK to treat people who have conditions such as angina or have suffered a heart attack.
For most patients the risk of complications is low, but for some, there is a higher risk of their heart failing during the procedure. Heart failure is a serious complication which can need treatment with a life support machine and lead to major damage to the heart muscle or even death. These risks are greatest in patients with severely diseased heart arteries and those who already have weakened heart muscle.
A new technology may be able to help with this problem. It consists of a small heart pump which is placed in the heart’s main pumping chamber (the left ventricle, LV). This pump is known as a LV unloading device. The LV unloading device is inserted into the heart through a blood vessel in the leg and supports the heart muscle. It is removed at the end of the procedure or when the heart can pump safely on its own. Whilst this heart pump is promising, it comes with some risks of its own. These include bleeding and damage to the arteries in the legs. It is also expensive, costing £8,000 per operation. Currently, there is no strong evidence to guide the use of this device.
The CHIP study aims to determine whether these heart pumps are beneficial and cost-effective in patients receiving a stenting procedure who are at high-risk of complications.
Who can participate?
This study is open to patients who are due to receive a Percutaneous Coronary Intervention (PCI), or stenting, to treat narrow arteries in their heart and whose doctor believes they are at high-risk of complications.
How long will the study run for?
CHIP-BCIS3 will open to recruitment in summer 2021 and recruit participants for 3 years. The results of this important study are expected in 2026.
For more information, please email chip-bcis3@lshtm.ac.uk.
Current trial protocol
Recent updates
Events
Newsletter
Contact us
CHIP-BCIS3 Clinical Trials Unit
Department of Medical Statistics
London School of Hygiene and Tropical Medicine
Keppel Street
London WC1E 7HT
We would like to notify all study participants about an important change in how we handle your data as part of the CHIP-BCIS3 trial.
What is changing?
When you joined the study, you gave your permission for us to collect your NHS number and date of birth, and to share your NHS number with NHS England and other central UK government bodies. We are now planning to share your date of birth with NHS England as well.
Does this change affect you?
If you were consented to Versions 1.4 or later of the PIS and consent form, you have already consented to share your date of birth and this change does not affect you.
For participants who were consented before Versions 1.4 of the PIS and consent form, this change does affect you. We have received special approval (‘section 251’ support) from the Confidential Advisory Group (CAG) to share your date of birth with NHS England without needing to ask for your consent. The CAG is an independent group of people who checks that confidential patient information is used appropriately and is in the best interest of patients and the public.
Why is this change needed?
When NHS England check health records for research, they need two pieces of information to match records. When we wrote the initial PIS and consent form, we did not know we needed to share your date of birth with NHS England. NHS England hold this information already, but need us to confirm it in order to make sure it’s your information that they give us. We need your information from NHS England to collect accurate information about your health and make the results of our research more reliable and useful to patients and people working for the NHS.
How is your data kept safe?
Your privacy is our priority. Access to information that could identify you is strictly controlled and is only accessible by members of the study team. Your data will be in a form that will not contain anything that identifies you personally. We will continue using your allocated study ID number instead of your name or other identifiable information to protect your confidentiality. All identifiable information will be stored in a secure encrypted database at the London School of Hygiene and Tropical Medicine and shared securely with NHS England and other central UK government bodies.
How do I opt out of sharing my date of birth?
If you consent to these changes, you do not need to do anything.
If you do not want your date of birth to be shared with NHS England, you can opt-out by contacting the research team at the hospital where you were involved in the CHIP-BCIS3 trial. This information can be found in the Patient Information Sheet given to you when you decided to take part in the study. If you choose to opt out, this will not affect your medical care or taking part in the study.
Participant documents
Recent updates
Events
Newsletter
Contact us
CHIP-BCIS3 Clinical Trials Unit
Department of Medical Statistics
London School of Hygiene and Tropical Medicine
Keppel Street
London WC1E 7HT
Our current site collaborators

- Barts Heart Centre, London
- Bristol Heart Institute
- Essex Cardiothoracic Centre, Basildon
- Freeman Hospital, Newcastle
- Glenfield Hospital, Leicester
- Golden Jubilee National Hospital, Glasgow
- Harefield Hospital, London
- John Radcliffe Hospital, Oxford
- King's College Hospital, London
- Manchester Royal Infirmary
- Morriston Hospital, Swansea
- Musgrove Park Hospital, Taunton
- New Cross Hospital, Wolverhampton
- Queen Elizabeth Hospital, Birmingham
- Royal Bournemouth Hospital
- Royal Brompton Hospital, London
- Royal Cornwall Hospital, Truro
- Royal Sussex Hospital, Brighton
- Royal Victoria Hospital, Belfast
- St George's Hospital, London
- St Thomas' Hospital, London
Recent updates
Events
Newsletter
Contact us
CHIP-BCIS3 Clinical Trials Unit
Department of Medical Statistics
London School of Hygiene and Tropical Medicine
Keppel Street
London WC1E 7HT
Randomisation system guidance
View the Randomisation system guidance.
ECRF training guidance
View the ECRF training guidance.
Newsletters
2022
2023
2024
Recent updates
Events
Newsletter
Contact us
CHIP-BCIS3 Clinical Trials Unit
Department of Medical Statistics
London School of Hygiene and Tropical Medicine
Keppel Street
London WC1E 7HT
CHIP-BCIS3 is a collaboration between King’s College London, Guy’s and St Thomas’ NHS Foundation Trust and the London School of Hygiene & Tropical Medicine.
Divaka Perera
Professor and Chief Investigator, King’s College London and St Thomas’ Hospital

Tim
Clayton
Professor in Applied Medical Statistics / Principle Investigator
Matt Ryan
Clinical Senior Lecturer
Richard Evans
Senior Manager of the Clinical Trials Unit
Matthew Kwok
Trial Manager
Steven Robertson
Senior Data Manager
Laura van Dyck
Data Manager
Lynn Laidlaw
Patient Representative
Megan Knight
Assistant Trial Manager
Recent updates
Events
Newsletter
Contact us
CHIP-BCIS3 Clinical Trials Unit
Department of Medical Statistics
London School of Hygiene and Tropical Medicine
Keppel Street
London WC1E 7HT
Recent updates
Events
Newsletter
Contact us
CHIP-BCIS3 Clinical Trials Unit
Department of Medical Statistics
London School of Hygiene and Tropical Medicine
Keppel Street
London WC1E 7HT